1. Janux Therapeutics Inc
  2. Janux Therapeutics Inc Ownership

Historical shareholding details of iShares Nasdaq US Biotechnology ETF holdings in Janux Therapeutics Inc (JANX)

Monthly changes of iShares Nasdaq US Biotechnology ETF shareholding in Janux Therapeutics Inc over the previous months

Month Name Total no. shares held Percent Holding
Feb 28, 2025 Ishares Nasdaq Us Biotechnology Etf 26,145 0.04%
Feb 26, 2025 Ishares Nasdaq Us Biotechnology Etf 26,145 0.04%
Jan 31, 2025 Ishares Nasdaq Us Biotechnology Etf 25,405 0.04%
Jan 29, 2025 Ishares Nasdaq Us Biotechnology Etf 25,405 0.04%
Dec 31, 2024 Ishares Nasdaq Us Biotechnology Etf 25,241 0.04%
Dec 30, 2024 Ishares Nasdaq Us Biotechnology Etf 25,241 0.04%
Nov 30, 2024 Ishares Nasdaq Us Biotechnology Etf 28,316 0.05%
Nov 27, 2024 Ishares Nasdaq Us Biotechnology Etf 28,316 0.05%
Oct 31, 2024 Ishares Nasdaq Us Biotechnology Etf 29,756 0.06%
Oct 30, 2024 Ishares Nasdaq Us Biotechnology Etf 29,756 0.06%
Sep 30, 2024 Ishares Nasdaq Us Biotechnology Etf 29,504 0.06%
Sep 27, 2024 Ishares Nasdaq Us Biotechnology Etf 29,504 0.06%
Sep 25, 2024 Ishares Nasdaq Us Biotechnology Etf 29,414 0.06%
Aug 30, 2024 Ishares Nasdaq Us Biotechnology Etf 28,874 0.06%
Aug 28, 2024 Ishares Nasdaq Us Biotechnology Etf 28,874 0.06%
Jul 31, 2024 Ishares Nasdaq Us Biotechnology Etf 29,504 0.06%
Jul 29, 2024 Ishares Nasdaq Us Biotechnology Etf 29,504 0.06%
Jun 28, 2024 Ishares Nasdaq Us Biotechnology Etf 29,504 0.06%
Jun 25, 2024 Ishares Nasdaq Us Biotechnology Etf 29,504 0.06%
May 29, 2024 Ishares Nasdaq Us Biotechnology Etf 26,868 0.05%
Apr 26, 2024 Ishares Nasdaq Us Biotechnology Etf 26,868 0.05%
Mar 29, 2024 Ishares Nasdaq Us Biotechnology Etf 27,288 0.05%
Mar 27, 2024 Ishares Nasdaq Us Biotechnology Etf 27,288 0.05%
Feb 29, 2024 - - 0.05%
Feb 27, 2024 Ishares Nasdaq Us Biotechnology Etf 22,914 0.05%
Jan 31, 2024 Ishares Nasdaq Us Biotechnology Etf 22,992 0.05%
Dec 27, 2023 Ishares Nasdaq Us Biotechnology Etf 22,686 0.05%
Dec 16, 2022 Ishares Nasdaq Us Biotechnology Etf 0 0.00%

View all ownership details of Janux Therapeutics Inc